A new study, released on the bioRxiv* preprint server, shows that rapamycin, an immunosuppressive drug used in some cancers, and
Continue reading »Home » Sars-CoV-2 »
Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection
By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Continue reading »SARS-CoV-2: New findings on the persistence of neutralizing antibodies
It is an open question to what extent protection against reinfection persists after overcoming a SARS-CoV-2 infection. The “Rhineland Study”,
Continue reading »Microbiota-derived molecules do not change the entry or replication of SARS-CoV-2 in intestinal cells
A study conducted at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, shows that compounds produced
Continue reading »SARS-CoV-2 mutation T478K spreading at alarming speed in Mexico
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »SARS-CoV-2 mutation T478K spreading at alarming speed in Mexico
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »Community exposures tied to SARS-CoV-2 seropositivity in HCWs
(HealthDay)—Community exposures, but not workplace factors, are associated with seropositivity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among health
Continue reading »In his continued sparring with Fauci, Sen. Rand Paul oversimplified the science
That Sen. Rand Paul of Kentucky often disagrees with infectious-disease expert Dr. Anthony Fauci is well known. Recently, the pair
Continue reading »Combined clinical and genomic data better predicts COVID-19 severity
The current COVID-19 outbreak is one of the worst pandemics in history and has claimed millions of lives across the
Continue reading »Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug
Scientists have found new, unexpected behaviors when SARS-CoV-2—the virus that causes COVID-19—encounters drugs known as inhibitors, which bind to certain
Continue reading »